Diagnostic Performance and Usability of the Genedrive(®) HCV ID Kit in Two Decentralized Settings in Cameroon and Georgia

Point-of-care diagnostics have the potential to increase diagnosis and linkage to care and help reach the WHO targets to eliminate hepatitis C virus (HCV) by 2030. Here, we evaluated the diagnostic accuracy of Genedrive HCV ID assay for the qualitative detection of HCV RNA in decentralized settings...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamoury, Francois M. J., Njouom, Richard, Amougou-Atsama, Marie, Yiagnigni Mfopou, Euloge, Berishvili, Nino, Sologashvili, Manana, Fajardo, Emmanuel, Malobela, Agnes, Macé, Aurélien, Chirehwa, Maxwell, Alkhazashvili, Maia, Ivanova Reipold, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143533/
https://www.ncbi.nlm.nih.gov/pubmed/33921930
http://dx.doi.org/10.3390/diagnostics11050746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143533/
https://www.ncbi.nlm.nih.gov/pubmed/33921930
http://dx.doi.org/10.3390/diagnostics11050746

Ejemplares similares